A citation-based method for searching scientific literature

Katarzyna Kamińska, Ewelina Nalejska, Marta Kubiak, Joanna Wojtysiak, Łukasz Żołna, Janusz Kowalewski, Marzena Anna Lewandowska. Mol Diagn Ther 2019
Times Cited: 32







List of co-cited articles
174 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Regulation of chromatin by histone modifications.
Andrew J Bannister, Tony Kouzarides. Cell Res 2011
12

Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription.
Claire E Barnes, David M English, Shaun M Cowley. Essays Biochem 2019
107
12


Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Somaia E Elsheikh, Andrew R Green, Emad A Rakha, Des G Powe, Rabab A Ahmed, Hilary M Collins, Daniele Soria, Jonathan M Garibaldi, Claire E Paish, Amr A Ammar,[...]. Cancer Res 2009
297
12

Histone Modifications and Cancer.
James E Audia, Robert M Campbell. Cold Spring Harb Perspect Biol 2016
378
12

DNA methylation and its basic function.
Lisa D Moore, Thuc Le, Guoping Fan. Neuropsychopharmacology 2013
12


Epigenetic Alterations in Bladder Cancer.
Sima P Porten. Curr Urol Rep 2018
32
9

Clinical epigenetics: seizing opportunities for translation.
María Berdasco, Manel Esteller. Nat Rev Genet 2019
240
9

Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Laia Simó-Riudalbas, Manel Esteller. Br J Pharmacol 2015
65
9

Histone Deacetylase Inhibitors as Anticancer Drugs.
Tomas Eckschlager, Johana Plch, Marie Stiborova, Jan Hrabeta. Int J Mol Sci 2017
636
9

Histone ubiquitination: triggering gene activity.
Vikki M Weake, Jerry L Workman. Mol Cell 2008
482
9

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
9

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
9

CpG islands and the regulation of transcription.
Aimée M Deaton, Adrian Bird. Genes Dev 2011
9


microRNAs as oncogenes and tumor suppressors.
Baohong Zhang, Xiaoping Pan, George P Cobb, Todd A Anderson. Dev Biol 2007
9

Epigenetics in cancer.
Shikhar Sharma, Theresa K Kelly, Peter A Jones. Carcinogenesis 2010
9

The 5-methylcytosine content of DNA from human tumors.
M A Gama-Sosa, V A Slagel, R W Trewyn, R Oxenhandler, K C Kuo, C W Gehrke, M Ehrlich. Nucleic Acids Res 1983
650
9

Diagnostic and prognostic epigenetic biomarkers in cancer.
Pedro Costa-Pinheiro, Diana Montezuma, Rui Henrique, Carmen Jerónimo. Epigenomics 2015
122
9


Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
Bernardo P de Almeida, Joana Dias Apolónio, Alexandra Binnie, Pedro Castelo-Branco. BMC Cancer 2019
56
9


Epigenetic silencing of the PTEN gene in melanoma.
Alireza Mirmohammadsadegh, Alessandra Marini, Sandeep Nambiar, Mohamed Hassan, Andrea Tannapfel, Thomas Ruzicka, Ulrich R Hengge. Cancer Res 2006
193
9

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.
Andrew P Feinberg, Michael A Koldobskiy, Anita Göndör. Nat Rev Genet 2016
486
9

DNMT Inhibitors Increase Methylation in the Cancer Genome.
Anil K Giri, Tero Aittokallio. Front Pharmacol 2019
39
9

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.
Yuan Cheng, Cai He, Manni Wang, Xuelei Ma, Fei Mo, Shengyong Yang, Junhong Han, Xiawei Wei. Signal Transduct Target Ther 2019
308
9

H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy.
Marta Hałasa, Anna Wawruszak, Alicja Przybyszewska, Anna Jaruga, Małgorzata Guz, Joanna Kałafut, Andrzej Stepulak, Marek Cybulski. Cells 2019
24
12

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
J G Herman, A Merlo, L Mao, R G Lapidus, J P Issa, N E Davidson, D Sidransky, S B Baylin. Cancer Res 1995
9

Genomic imprinting disorders: lessons on how genome, epigenome and environment interact.
David Monk, Deborah J G Mackay, Thomas Eggermann, Eamonn R Maher, Andrea Riccio. Nat Rev Genet 2019
156
9


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
9

DNA methylation pathways and their crosstalk with histone methylation.
Jiamu Du, Lianna M Johnson, Steven E Jacobsen, Dinshaw J Patel. Nat Rev Mol Cell Biol 2015
507
9

Histone arginine methylation.
Alessandra Di Lorenzo, Mark T Bedford. FEBS Lett 2011
303
6

The Epigenetic Regulation of HCC Metastasis.
Tae-Su Han, Hyun Seung Ban, Keun Hur, Hyun-Soo Cho. Int J Mol Sci 2018
61
6

Levels of histone acetylation in thyroid tumors.
Cinzia Puppin, Nadia Passon, Elisa Lavarone, Carla Di Loreto, Francesco Frasca, Veronica Vella, Riccardo Vigneri, Giuseppe Damante. Biochem Biophys Res Commun 2011
34
6

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.
Matthew F Barber, Eriko Michishita-Kioi, Yuanxin Xi, Luisa Tasselli, Mitomu Kioi, Zarmik Moqtaderi, Ruth I Tennen, Silvana Paredes, Nicolas L Young, Kaifu Chen,[...]. Nature 2012
393
6

Acetylation and deacetylation in cancer stem-like cells.
Na Liu, Shiqi Li, Nan Wu, Kin-Sang Cho. Oncotarget 2017
48
6

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Terri L Messier, Jonathan A R Gordon, Joseph R Boyd, Coralee E Tye, Gillian Browne, Janet L Stein, Jane B Lian, Gary S Stein. Oncotarget 2016
60
6



Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma.
Hassan Ashktorab, Kevin Belgrave, Fatemeh Hosseinkhah, Hassan Brim, Mehdi Nouraie, Mikiko Takkikto, Steve Hewitt, Edward L Lee, R H Dashwood, Duane Smoot. Dig Dis Sci 2009
81
6

Erasers of histone acetylation: the histone deacetylase enzymes.
Edward Seto, Minoru Yoshida. Cold Spring Harb Perspect Biol 2014
917
6

Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.
Eunah Kim, William H Bisson, Christiane V Löhr, David E Williams, Emily Ho, Roderick H Dashwood, Praveen Rajendran. Curr Top Med Chem 2016
40
6

Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.
Camille Brochier, Gretel Dennis, Mark A Rivieccio, Kathryn McLaughlin, Giovanni Coppola, Rajiv R Ratan, Brett Langley. J Neurosci 2013
70
6

Enhanced histone acetylation and transcription: a dynamic perspective.
Alison L Clayton, Catherine A Hazzalin, Louis C Mahadevan. Mol Cell 2006
342
6

Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
Shivashankar Damodaran, Nathan Damaschke, Joseph Gawdzik, Bing Yang, Cedric Shi, Glenn O Allen, Wei Huang, John Denu, David Jarrard. BMC Cancer 2017
30
6

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases.
Somy Yoon, Gwang Hyeon Eom. Chonnam Med J 2016
229
6

Bisubstrate inhibitors to target histone acetyltransferase 1.
Liza Ngo, Tyler Brown, Yujun G Zheng. Chem Biol Drug Des 2019
12
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.